Rebecca Lai Email & Phone Number

San Francisco, Ca, Us

Independent firm specializing in go-to-market, product, commercialization and corporate strategy at healthtech companies. Fractional executive and C-suite strategy advisor for fundraising, value creation and go-to-market activities. Expertise in AI, device therapeutics, diagnostics, and clinical services.

Stanford, California, Us

Diversity by Doing HealthTech (DxD) is an industry-based collaborative with a mission to enhance diversity, inclusion and equity in the health technology innovation ecosystem with a particular focus on early to mid-stage companies.

San Francisco, Ca, Us

iRhythm (Nasdaq: IRTC) is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information.Led strategic planning, growth innovation, new business development and partnerships.

San Francisco, Ca, Us

Managed P&L with 50 employees across operational to commercial teams.

San Francisco, Ca, Us

Part of IPO team. Identified and incubated business growth levers. Owned market research and competitive intelligence.

Independent firm focused on product and marketing strategies at early-stage to Fortune 500 medtech and digital health companies.Fractional positions at early-stage, emerging and growth companies developing near- and long-term commercial plans for wearables, digital platform solutions and novel technologies.

Fridley, Minnesota, Us

Reinventing what's humanly possible.Health Informatics & Monitoring Solutions from Medtronic give clinicians the ability to remotely view vital information from multiple device categories. Thanks to wireless sensors, clinicians are able to monitor patients’ vitals – even while away from the patient or hospital. The preventable can often be prevented. And the standard of health care raised to an even higher level.Covidien was acquired by Medtronic in January 2015.

Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company’s initial product, the Pulsante™ SPG Microstimulator System (ATI Neurostimulation System), is CE-marked in Europe for the relief of acute pain of cluster headache.ATI, a Cleveland Clinic Innovations spinoff, is backed by blue chip investors Kleiner Perkins Caufield and Byers, InterWest Partners, Versant Ventures, Novartis Ventures, Aberdare Ventures, and the Cleveland Clinic.

Minneapolis, Mn, Us

Orchestrated a global expansion program for CryoCath and Ablation Frontiers acquisitions targeting a 30% increase in global footprint and doubling total revenue within 3 years.Designed product launch strategies for the Arctic Front System in diverse markets like India, Latin America and Japan determining capital and disposable sales models to meet revenue and profitability goals. Managed 30+ person team for product approval and launch of Arctic Front System in Japan resulting in launch in less than 3 years from project initiation.

Minneapolis, Mn, Us

Managed a team of 20 individuals across business units to develop a compelling case for innovation, change and investment in Sub-Saharan Africa. Delivered final recommendation to Medtronic executive management team to include 3 disciplined experiments that will test for scalable and sustainable solutions in 5-year strategic plan.

Minneapolis, Mn, Us

Led alignment efforts across diverse regions including Europe, Japan, Canada, Asia Pacific, Middle East Africa, Japan, India, and Latin America for telehealth, eHealth, analytics, and connectivity solutions. Successfully differentiated a $5B business during a global economic downturn.Optimized operations for CareLink, the world's leading remote monitoring system for implantable devices, across 31 countries. Doubled enrollments within 18 months, facilitating the virtualization of patient follow-up.Launched a series of products within 18 months, introducing 4 pipeline products to market. Developed a global marketing plan for an additional 5 products at various stages of the product launch cycle.

Minneapolis, Mn, Us

Launched next generation cardiac rhythm product portfolio and remote device monitoring system. Established Bakken Education Center- Africa collaborating with US and European headquarters to leverage training curriculum and best practices. Training facilities attracted support of the Ministry of Health for expanding physician skill base in Sub-Saharan Africa. Solidified Medtronic's market leadership, maintaining 80% market share and continuing 20% growth in the defibrillator and heart failure business in a declining worldwide market.

Minneapolis, Mn, Us

Managed the mobile virtual cath lab (VCL), a multi-million dollar franchise experiment, leading to exposure of over 5000 U.S. customers and consumers to Medtronic products and therapies in 2 years. Responsibilities include asset management, expense control, inventory forecasting, metric tracking and vendor and operations management. Formed strategic alliances across businesses and geographies, expanding the impact of Medtronic's VCL program. Facilitated a train-the-trainer program in China, leveraging the China VCL to train 1100 physicians in the next 3 years.

Minneapolis, Mn, Us

A diverse role supporting a top revenue producing sales district spanning 5 highly successful growth years. Established customer loyalty with 40 electrophysiologists through providing technical expertise and concierge service for cardiac rhythm products. Supervised and trained 12 new hires partnering with district manager to provide performance feedback. Managed over 14 investigational and outcomes clinical studies from site nomination to follow-up. Launched 40 products in 5 years.

Mse, Professional Masters In Biomedical Engineering

Bse, Bioengineering

Certificate, Biostatistics And Epidemiology